Brutons tyrosine kinase inhibitor Zanubrutinib modulates Fc gamma receptors to inhibit platelet destruction for alleviation of refractory immune thrombocytopenia.
Saved in:
| Title: | Brutons tyrosine kinase inhibitor Zanubrutinib modulates Fc gamma receptors to inhibit platelet destruction for alleviation of refractory immune thrombocytopenia. |
|---|---|
| Authors: | Yang XX; Department of Hematology, First People's Hospital of Linping District, Hangzhou, People's Republic of China., Yao GL; Department of Hematology, First People's Hospital of Linping District, Hangzhou, People's Republic of China., Yang YJ; Department of Hematology, First People's Hospital of Linping District, Hangzhou, People's Republic of China., Han YH; Department of Hematology, First People's Hospital of Linping District, Hangzhou, People's Republic of China., Yang L; Department of Hematology, First People's Hospital of Linping District, Hangzhou, People's Republic of China., Zhang YF; Department of Hematology, First People's Hospital of Linping District, Hangzhou, People's Republic of China. |
| Source: | Hematology (Amsterdam, Netherlands) [Hematology] 2025 Dec; Vol. 30 (1), pp. 2545078. Date of Electronic Publication: 2025 Oct 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1607-8454 (Electronic) Linking ISSN: 10245332 NLM ISO Abbreviation: Hematology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1607-8454 |
|---|---|
| DOI: | 10.1080/16078454.2025.2545078 |
